The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on June 9, 2026

Jun. 9, 2026

Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update

Indeterminate GlobeNewswire

Jun. 9, 2026

Aduro Reports NGP Pilot Plant Campaign Results, Achieving 86% Liquid Hydrocarbon Yield

Indeterminate GlobeNewswire

Jun. 9, 2026

Micware Co., Ltd. Rings the Closing Bell to Celebrate its Nasdaq Global Market Listing

Indeterminate GlobeNewswire

Jun. 9, 2026

ミックウェア、クロージングベルを鳴らしNasdaq Global Market上場を祝賀

Indeterminate GlobeNewswire

Jun. 9, 2026

House of Doge and MoonPay Enable Dogecoin Payments Across 6,000+ Merchants and Launch “ÐOGE Pay”

Indeterminate GlobeNewswire

Jun. 9, 2026

Infrastructure Monitoring and Control Provider Acorn to Webcast Investor Presentation at Planet MicroCap Las Vegas Powered by MicroCapClub Conference Wed. June 17 at 12:30 PT

Indeterminate GlobeNewswire

Jun. 9, 2026

Applied Digital Announces Proposed Offering of $1.59 Billion of Senior Secured Notes to fund the Fourth Building at Polaris Forge 1

Indeterminate GlobeNewswire

Jun. 9, 2026

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

Indeterminate GlobeNewswire

Jun. 9, 2026

ZenaTech Added to Russell 3000® Index, Marking Major Milestone in Company's Growth and Market Recognition

Indeterminate GlobeNewswire

Jun. 9, 2026

Applied Materials Announces Cash Dividend

Indeterminate GlobeNewswire

Jun. 9, 2026

Cineplex Reports Highest May Box Office since 2019

Indeterminate GlobeNewswire

Jun. 9, 2026

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Indeterminate GlobeNewswire

Jun. 9, 2026

TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial

Indeterminate GlobeNewswire

Jun. 9, 2026

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

Indeterminate GlobeNewswire

Jun. 9, 2026

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jun. 9, 2026

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Indeterminate GlobeNewswire

Jun. 9, 2026

Verified Once, Trusted Forever? Regula to Discuss the Future of Age Assurance at Identity Week Europe 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Indeterminate GlobeNewswire

Jun. 9, 2026

FLYR and Res2 Partner to Accelerate Order-Based Delivery

Indeterminate GlobeNewswire

Jun. 9, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Indeterminate GlobeNewswire